ArisGlobal https://www.arisglobal.com/ Wed, 11 Dec 2024 11:32:50 +0000 en-US hourly 1 https://wordpress.org/?v=6.6.2 ArisGlobal Unveils LifeSphere Safety 24.3, Featuring New Generative AI and Advanced Safety Management Capabilities https://www.arisglobal.com/media/press-release/arisglobal-unveils-lifesphere-safety-24-3-featuring-new-generative-ai-and-advanced-safety-management-capabilities/ Wed, 11 Dec 2024 11:32:50 +0000 https://www.arisglobal.com/?p=50953 The latest release brings AI-powered Narrative Generation, enhanced Business Intelligence, and seamless data integrations, empowering life sciences companies to enhance patient safety, quality, and compliance.

The post ArisGlobal Unveils LifeSphere Safety 24.3, Featuring New Generative AI and Advanced Safety Management Capabilities appeared first on ArisGlobal.

]]> The Economic Case for Automation & GenAI in Life Sciences R&D: Converting Potential https://www.arisglobal.com/article/the-economic-case-for-automation-genai-in-life-sciences-rd-converting-potential/ Mon, 09 Dec 2024 20:52:43 +0000 https://www.arisglobal.com/?p=50943 An ArisGlobal best practice guide, informed by investor insight from Nordic Capital

The post The Economic Case for Automation & GenAI in Life Sciences R&D: Converting Potential appeared first on ArisGlobal.

]]> Moving to the Cloud to Enable Next-Gen Pharmacovigilance, a Top 15 BioPharma Chooses LifeSphere® End-to-End Safety Platform https://www.arisglobal.com/media/press-release/moving-to-the-cloud-to-enable-next-gen-pharmacovigilance-a-top-15-biopharma-chooses-lifesphere-end-to-end-safety-platform/ Wed, 04 Dec 2024 12:46:05 +0000 https://www.arisglobal.com/?p=50933 The multinational biopharma company, which previously used a series of on-premise point solutions, will implement LifeSphere Safety due to the platform’s AI-based innovation and modern multi-tenant cloud delivery.

The post Moving to the Cloud to Enable Next-Gen Pharmacovigilance, a Top 15 BioPharma Chooses LifeSphere® End-to-End Safety Platform appeared first on ArisGlobal.

]]> 5 Reasons You Can’t Miss Breakthrough 2025 https://www.arisglobal.com/blogs/5-reasons-you-cant-miss-breakthrough-2025/ Mon, 02 Dec 2024 16:51:56 +0000 https://www.arisglobal.com/?p=50926 Breakthrough 2025 is set to be a pivotal event for safety, regulatory, and life sciences professionals.

The post 5 Reasons You Can’t Miss Breakthrough 2025 appeared first on ArisGlobal.

]]> PharmaTimes – Reflections and predictions – our luminaries look across the pharmaverse with conclusions and curiosity https://www.arisglobal.com/media/media-coverage/pharmatimes-reflections-and-predictions-our-luminaries-look-across-the-pharmaverse-with-conclusions-and-curiosity/ Mon, 02 Dec 2024 10:08:00 +0000 https://www.arisglobal.com/?p=50924 The post <i>PharmaTimes</i> – Reflections and predictions – our luminaries look across the pharmaverse with conclusions and curiosity appeared first on ArisGlobal.

]]> Survey: Unsustainable Regulatory Workloads Leave No Choice About AI Adoption https://www.arisglobal.com/media/press-release/survey-regulatory-workloads-ai-adoption/ Tue, 12 Nov 2024 13:45:21 +0000 https://www.arisglobal.com/?p=50867 It is now imperative for life science companies to optimize Regulatory Affairs resources using next-generation technology if they are to ensure affordable patient access to treatments and achieve commercial viability, new independent research finds. Boston, Massachusetts – November 12, 2024 – ArisGlobal, an innovative technology company at the forefront of life sciences and creator of LifeSphere®, ...

The post Survey: Unsustainable Regulatory Workloads Leave No Choice About AI Adoption appeared first on ArisGlobal.

]]> Forbes – Why all eyes are on Life Sciences for its GenAI use https://www.arisglobal.com/media/media-coverage/forbes-why-all-eyes-are-on-life-sciences-for-its-genai-use/ Thu, 31 Oct 2024 06:55:42 +0000 https://www.arisglobal.com/?p=50837 The post <i>Forbes</i> – Why all eyes are on Life Sciences for its GenAI use appeared first on ArisGlobal.

]]> Journal of Clinical Studies – Generating Entire Regulatory Dossiers – The Logical Next Step for GenAI in Life Sciences https://www.arisglobal.com/media/media-coverage/journal-of-clinical-studies-generating-entire-regulatory-dossiers-the-logical-next-step-for-genai-in-life-sciences/ Wed, 30 Oct 2024 14:38:25 +0000 https://www.arisglobal.com/?p=50836 The post <i>Journal of Clinical Studies</i> – Generating Entire Regulatory Dossiers – The Logical Next Step for GenAI in Life Sciences appeared first on ArisGlobal.

]]> What to Expect and What’s Trending in Regulatory Affairs https://www.arisglobal.com/blogs/what-to-expect-and-whats-trending-in-regulatory-affairs/ Thu, 24 Oct 2024 08:37:07 +0000 https://www.arisglobal.com/?p=50800 In the rapidly evolving landscape of regulatory affairs, significant advancements and trends are shaping the future. At ArisGlobal, we're committed to staying at the forefront of these changes and ensuring our clients are well-prepared. Here's a deep dive into the latest developments and what to expect in the coming years. 

The post What to Expect and What’s Trending in Regulatory Affairs appeared first on ArisGlobal.

]]> Webinar: Driving Value in Pharmacovigilance https://www.arisglobal.com/webinar/webinar-driving-value-pv/ https://www.arisglobal.com/webinar/webinar-driving-value-pv/#respond Fri, 11 Oct 2024 12:19:25 +0000 https://www.arisglobal.com/?p=50649 Join us for an insightful panel discussion where global leaders in pharmaceutical IT and pharmacovigilance share their expertise on getting the most value out of their technology investments, including significant efficiency and cost savings. This session will provide practical advice and best practices around setting clear goals, advocating for ongoing investment in new ...

The post Webinar: Driving Value in Pharmacovigilance appeared first on ArisGlobal.

]]> https://www.arisglobal.com/webinar/webinar-driving-value-pv/feed/ 0